# Blood Compatibility Characteristics of Baxter Xenium+, Fresenius FX and Gambro Polyflux Dialyzers

> **NCT01273870** · — · COMPLETED · sponsor: **Praxisverbund Dialyse und Apherese** · enrollment: 8 (actual)

## Conditions studied

- End Stage Renal Failure on Dialysis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01273870
- **Lead sponsor:** Praxisverbund Dialyse und Apherese
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2011-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273870, "Blood Compatibility Characteristics of Baxter Xenium+, Fresenius FX and Gambro Polyflux Dialyzers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01273870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*